Dr. Herbert Strobl is a clinical immunologist, full professor of immunology and chairman of the Division of Immunology at Otto Loewi Research Center, Medical University Graz, Austria. He was elected founding head of the Otto Loewi Research Center in 2018. His research has been focussed on clinical laboratory hematology and immunology, dendritic cell biology and the characterization of normal and leukemic hematopoietic stem cells. The Strobl research laboratory was established upon recipient of the year 2000 prestigious START award of the Austrian government and Austrian science fund FWF. Following 12 years in Vienna, his lab moved to Medical University Graz during years 2012-2014, where he accepted a position of Full Professor in 2012. Prior to this he was a tenured Associate Professor (Ao Prof.) at Medical University Vienna/University Vienna since 2001. His initial training in basic and clinical immunology was with Prof. Walter Knapp (Institute of Immunology, University Vienna) starting from year 1989 prior to graduating as MD at University Vienna in 1991. He was trained in clinical immunology and served as a clinical consultant for leukemia/lymphoma immunophenotyping from 1991-1998 and 2001-2012, with hematology departments at St. Anna Chidren's Hospital Vienna and Hanusch Hospital Vienna. During this time several advances in flow-based immunophenotyping of acute leukemias were introduced. In 1994, he joined the VIRCC branch of the Institute of Immunology, University Vienna, located at Novartis Research Institute Vienna, where he took over a junior group leader position in hematopoiesis research. He received post doctoral training in molecular biology with Prof. Garry P. Nolan at Stanford University from 1998-2001. After returning to Vienna in 2001, he then applied retroviral vector methodology and screens for studying mechanisms in myelopoiesis and dendritic cell development. The Strobl lab pioneered the generation of human Langerhans-type dendritic cells in vitro from human CD34+ hematopoietic progenitor cells under defined serum-free conditions, based on their discovery in 1996 that the cytokine TGF-beta1 induces Langerhans cell differentiation. Based on differentiation models, they subsequently delineated molecular mechanisms underlying myelomonocytic cell and DC subset differentiation. The Strobl lab currently uses human and murine models for studying DC subset differentiation, and DC`s involvement in immune homeostasis and disease processes.